Recall of INTESYS CLINICAL SUITE (ICS) G2 - SMART DISCLOSURE

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SPACELABS HEALTHCARE (CANADA) INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    23894
  • Event Risk Class
    III
  • Event Initiated Date
    2014-03-07
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Inform about defect in the ics g2 clinical access software cd. the programs installed on the clinical access cd are incorrect and will prevent from installing clinical access. no one has been injured as a result of this issue and no data on the database is at risk.

Device

  • Model / Serial
    Model Catalog: 92810 (Lot serial: 063-1829-11)
  • Product Description
    Intesys Clinical Suite (ICS) G2 Full/Smart Disclosure
  • Manufacturer

Manufacturer

  • Manufacturer Address
    MISSISSAUGA
  • Manufacturer Parent Company (2017)
  • Source
    HC